BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CrystalGenomics 

Daeduck BioCommunity
461-6 Jeonmin-dong, Yusung-gu
Taejon    305-390  Korea
Phone: 82-42-866-9300 Fax: 82-42-866-9301


SEARCH JOBS




Industry
Biotechnology






 Company News
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014 12:36:20 PM
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014 8:43:42 AM
CrystalGenomics Announces Positive Results Of Phase 3 Trial Of Polmacoxib (CG100649) In Patients With Osteoarthritis 3/13/2014 9:35:26 AM
CrystalGenomics Acquires Hwail Pharmaceutical Co., Ltd. 8/26/2013 9:23:29 AM
CrystalGenomics Reports Positive Top-Line Data from Phase 2a Study of CG400549 in Patients with Complicated Acute Bacterial Skin and Skin Structure Infections Caused by MRSA 1/7/2013 11:19:30 AM
Sigma-Aldrich Corporation (SIAL) Release: SAFC Enters South Korean BioPharma Market With CrystalGenomics Agreement 10/30/2012 9:35:29 AM
CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649 4/19/2012 9:45:26 AM
CrystalGenomics Initiates CG100649 Phase 2b Study in Patients with Osteoarthritis 6/1/2011 9:32:28 AM
CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study 5/12/2011 7:23:46 AM
CrystalGenomics to Present Preliminary Results from Recently Completed Supra-threshold Phase I MAD Study for CG100649, its Novel NSAID Candidate at the Arrowhead 4th Annual Pain Therapeutics Summit 10/4/2010 7:23:24 AM
123